一阶段个体参与者数据荟萃分析模型:估计治疗-协变量交互作用必须分离试验内与试验间信息以避免生态偏倚
该研究通过模拟和实例比较一阶段个体参与者数据(IPD)荟萃分析中固定效应与随机效应模型估计治疗-协变量交互作用。结果显示,必须按试验内均值中心化患者水平协变量以分离试验内与试验间信息,否则交互作用估计的偏倚和覆盖度可能受到不利影响,导致由生态偏倚驱动的错误结论。在五项癫痫试验的IPD荟萃分析中,合并试验内与试验间信息时年龄交互作用为-0.011(95%CI:-0.019至-0.003;p=0.004),分离后为-0.007(95%CI:-0.019至0.005;p=0.22),效应量和统计显著性大幅降低。作者建议荟萃分析者仅使用试验内信息检验个体预测因子,一阶段IPD模型应分离试验内与试验间信息以避免生态偏倚。
要点
- 一阶段IPD模型若合并试验内与试验间信息,交互作用估计可能受生态偏倚影响。
- 按试验内均值中心化患者水平协变量是分离试验内与试验间信息的关键。
- 五项癫痫试验实例中,年龄交互作用合并信息时-0.011(p=0.004),分离后-0.007(p=0.22)。
核心结论
- 一阶段IPD荟萃分析估计治疗-协变量交互作用时,必须按试验内均值中心化患者水平协变量以分离试验内与试验间信息,否则偏倚和覆盖度可能受到不利影响,导致生态偏倚驱动的错误结论。
- 作者建议荟萃分析者仅使用试验内信息检验个体预测因子,一阶段IPD模型应分离试验内与试验间信息以避免生态偏倚。
研究设计与样本
- 通过模拟和一项应用实例比较一阶段IPD荟萃分析中固定效应与随机效应模型,用于估计时间至事件数据的治疗-协变量交互作用。
- 应用实例为五项癫痫试验的IPD荟萃分析,考察年龄作为治疗效果修饰因子。
主要发现
- 合并试验内与试验间信息时,年龄交互作用为-0.011(95%CI:-0.019至-0.003;p=0.004),具有高度统计学显著性。
- 分离试验内与试验间信息后,年龄交互作用为-0.007(95%CI:-0.019至0.005;p=0.22),效应量和统计显著性大幅降低。
关键数值与推荐
- 一阶段IPD模型应分离试验内与试验间信息以避免生态偏倚(作者建议)。
- 荟萃分析者应仅使用试验内信息检验个体预测因子(作者建议)。
临床怎么用
- 作者建议在估计治疗-协变量交互作用时,按试验内均值中心化患者水平协变量以分离试验内与试验间信息。
- 作者建议荟萃分析者仅使用试验内信息检验个体预测因子,一阶段IPD模型应分离试验内与试验间信息以避免生态偏倚。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Stratified medicine utilizes individual-level covariates that are associated with a differential treatment effect, also known as treatment-covariate interactions. When multiple trials are available, meta-analysis is used to help detect true treatment-covariate interactions by combining their data. Meta-regression of trial-level information is prone to low power and ecological bias, and therefore, individual participant data (IPD) meta-analyses are preferable to examine interactions utilizing individual-level information. However, one-stage IPD models are often wrongly specified, such that interactions are based on amalgamating within- and across-trial information. We compare, through simulations and an applied example, fixed-effect and random-effects models for a one-stage IPD meta-analysis of time-to-event data where the goal is to estimate a treatment-covariate interaction. We show that it is crucial to centre patient-level covariates by their mean value in each trial, in order to separate out within-trial and across-trial information. Otherwise, bias and coverage of interaction estimates may be adversely affected, leading to potentially erroneous conclusions driven by ecological bias. We revisit an IPD meta-analysis of five epilepsy trials and examine age as a treatment effect modifier. The interaction is -0.011 (95% CI: -0.019 to -0.003; p = 0.004), and thus highly significant, when amalgamating within-trial and across-trial information. However, when separating within-trial from across-trial information, the interaction is -0.007 (95% CI: -0.019 to 0.005; p = 0.22), and thus its magnitude and statistical significance are greatly reduced. We recommend that meta-analysts should only use within-trial information to examine individual predictors of treatment effect and that one-stage IPD models should separate within-trial from across-trial information to avoid ecological bias. © 2016 The Authors. Statistics in Medicine published by John Wiley & Sons Ltd.
引用
- Hua H, Burke DL, Crowther MJ, et al. One-stage individual participant data meta-analysis models: estimation of treatment-covariate interactions must avoid ecological bias by separating out within-trial and across-trial information. Stat Med. 2016. PMID: 27910122. doi:10.1002/sim.7171
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。